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ABSTRACT
Objectives: The antioxidant activity of the synthesized compounds along with the standard compound for comparison is reported. There is comparison 
of binding analysis and the ligand interaction of the compound.
Methods: The protein crystal structure complexed with 4-methyl-6-[2-(5-morpholin-4-ylpyridin-3-yl)ethyl]pyridin-2-amine inhibitor was selected 
from Protein Data Bank (5FVP) for our study.
Results: The docking studies and structure-activity relationship reveals that the compound 2’-chloro-4-methoxy-3nitro benzilic acid after three 
different docking strategies reveals that the score was found to be higher compared with others.
Conclusion: Based on the in vitro antioxidant results, the compounds synthesized were investigated for the molecular docking study to identify the 
amino acid interactions in the active site pocket of nitric oxide synthase enzyme. Based on the docking score results, all the compounds were oriented 
toward the active site pocket occupied by the cocrystallized ligand.
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INTRODUCTION
Docking is frequently used to predict the binding orientation of small 
molecule drug candidates to their protein targets to predict the affinity 
and activity of the small molecule [1-5]. Hence, docking plays an 
important role in the 158 rational drug designs. Given the biological and 
pharmaceutical significance of molecular docking, considerable efforts 
have been directed toward improving the methods used to predict 
docking. A binding interaction between a small molecule ligand and 
enzyme protein may result in activation or inhibition of the enzyme. 
If the protein is a receptor, ligand binding may result in agonism or 
antagonism. Docking is molecular virtual screening, a computational 
method where the compounds could be assessed for their potential to 
bind specific sites on target molecules such as proteins, was employed 
in the study [6]. The pharmacokinetic properties were also predicted 
for future perspective of the small molecule compounds. Molecular 
docking studies are used to determine the interaction of two molecules 
and to find the best orientation of ligand which would form a complex 
with overall minimum energy. The small molecule, known as ligand 
usually fits within protein’s cavity which is predicted by the search 
algorithm. These protein cavities become active when they come in 
contact with any external compounds and are thus called as active 
sites commonly used in the field of drug design-most drugs are small 
organic molecules. In living organism, the reactive oxygen species are 
formed as by-product of metabolic reactions, which cause diseases due 
to the initiation of oxidative reaction in biomolecules [7-9]. The reactive 
oxidation species formed during the metabolic process are nullified by 
the antioxidant substance having high antiradical power [10,11].
Protein preparation and active site cavity validation of the protein 
nitric oxide synthase (NOS)
The retrieved protein was prepared and hydrogen atoms, water 
molecules were removed and prepared. The crystal ligand tetracyclic 
aza-amide was found to show hydrogen bonding interactions with 
Glu592 and Trp587 amino acid residues. To validate the docking 
program, the crystal ligand was prepared and redocked on to the grid 
of the active site. The docking score was found to be –6.670 kcal/mol. 
The diagrammatic representation of reference ligand is shown in Fig. 1. 
The active site of the protein was located, and grid files were generated 
using receptor grid generation panel. Grid size was found to be 20 Å and 
is used for all docking analysis.
The reference docking results showed that the compound exhibited 
similar interactions as that of the original crystal structure which 
was further confirmed with redocking with the RMSD of 1.85 Å. The 
superimposition of docked pose and original crystal ligand pose of 
tetracyclic aza-amide is presented in Fig. 2.
Docking analysis
The selected ligands were docked into the tetracyclic aza-amide 
active site using the default grid and finally selected as hits from high 
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Fig. 1: Binding analysis and the ligand interaction of the reference 
ligand
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throughput virtual screening with the criteria of docking score were 
further docked using Glide standard precision docking module, and 
filtered ligands were subjected to Glide XP docking analysis. The resulted 
compounds with docking scores were found to be in the range of –8.061 
to –4.272 kcal/mol. Although the docking score did not indicate the 
compound’s binding affinity, it was helpful in prioritizing/ranking 
the ligands. Final shortlisting of hit compounds was based on visual 
inspection of the important amino acid residues involved in binding 
that included hydrogen bonding with Asn569. The docking score for 
the shortlisted compounds is tabulated in Table 1.
RESULTS AND DISCUSSIONS
There were many crystal structures published in the Protein Data 
Bank (PDB) (www.rcsb.org/pdb) on NOS in complexes with ligands 
and fragments developed by fragment-based design with resolutions 
ranging from 2.1 to 2.14 Å. As we attempted to utilize the crystal 
structure of NOS in complex with an inhibitor nitric oxide (PDB ID: 
5FVP) with 2.1 Å resolution for further active site validation and 
docking analysis.
NOS enzyme crystal structure complexed with inhibitor was taken for 
our study to discover novel hit molecule for antioxidant drug discovery. 
The reference ligand was docked into the active site of the enzyme, and 
the docking score was found to be –6.637 kcal/mol. The amino group 
of reference ligand was found to interact with positively charged amino 
acid Glu592 and non-polar amino acid Trp587.
Later, the synthetic compounds selected for our study was made to 
dock into the active site pocket of the enzyme NOS and found that the 
compound 2’chloro-4-methoxy-3-nitro-benzilic acid was found to be 
–8.061 kcal/mol. The closer analysis of the compound was analyzed 
and found that the compound was found to interact with the amino 
acid Ser457 and the benzyl group is stacked with the non-polar amino 
acid Trp409. The 3-dimensional view of this molecule reveals that the 
compound was well fitted into the active site cavity which made this 
molecule more effective binding than the reference ligand. Furthermore, 
the nitro group and methoxyphenyl group was well surrounded by the 
non-polar amino acids. This results also signifies the in vitro antioxidant 
activity. The binding analysis and the ligand interaction diagram was 
depicted in the Fig. 3.
The compound 2,2’-dichlorobenzilic acid showed the docking score of 
–7.374 kcal/mol to further discuss about this compound binding analysis 
and interactions, the amino acid Ser457 donates one hydrogen atom to 
the compound and the chloro benzilic group was found to be interact with 
two stacking interaction with non-polar amino acids Trp409 and Phe584. 
Furthermore, the compound is fully surrounded by the non-polar amino 
acids such as Val567, Ala566, and Ile459 which made this compound 
possess better docking score than others. The binding analysis and the 
docking score of the compound were depicted in Fig. 4.
The compound 4,4’ dibromobenzilic acid showed the docking score 
of –7.083 kcal/mol. Further, the structure-activity relationship of this 
compound reveals that the bromophenyl group is showing a stacking 
interaction with Trp409. Due to the presence of bulky halogenic group 
present on the both the side of this compound, the compound tends to 
lose its activity on binding with the enzyme [12]. The binding analysis 
and the ligand interaction of the compound were depicted in Fig. 5.
The compound methyl benzilate possesses the docking score of 
–6.290 kcal/mol. The closer analysis of this compound shows that the 
two benzylic group was found to interact with non-polar amino acids 
Phe584 and Trp409. Furthermore, the carbonyl group of this compound 
found to interact with Ser457. The 3-dimensional representation of this 
molecule reveals that the compound is slightly away from the active site 
Table 1: Docking score and ligand interaction results for the synthesized compounds
S. No. Compound name Docking score kcal/mol Ligand interaction
1. 2’-chloro4-methoxy-3-nitro benzilic acid −8.061 Ser457, Trp409, Phe584
2. 2,2’-dichlorobenzilic acid −7.374 Ser457, Trp409, Phe584
3. 4,4’-dibromo benzilic acid −7.083 Trp409
4. Methyl benzilate −6.290 Trp409, Ser457
5. Diisopropyl ammounium benzilate −6.035 Trp409
6. Benzilic acid −4.272 Trp587
Fig. 2: Superimposition of docked pose of etracyclic aza-amide and 
original pose of tetracyclic aza-amide, where yellow color indicates 
the original ligand and the red color represents docked ligand
Fig. 3: The binding analysis and the ligand interaction for the 
compound 2’chloro-4-methoxy benzylic acid
Fig. 4: The binding analysis and the ligand interaction for the 
compound 2,2’ dichlorobenzilic acid
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Fig. 5: The binding analysis and the ligand interaction of the 
compound 4,4’dibromobenzilic acid
Fig. 6: The binding analysis and the ligand interaction of the 
compound methyl benzilate
Fig. 7: The binding analysis and the ligand interaction for the 
compound diisopropyl ammonium benzilate
Fig. 8: The binding analysis and the ligand interaction for the 
compound benzylic acid
which made this compound lesser active than others [13]. The binding 
analysis and the ligand interaction of the compound were depicted in 
Fig. 6.
The compound diisopropyl ammonium benzilate shows the docking 
score of –6.035 kcal/mol. The ligand interactions of this compound 
reveal that the benzyl group was found to interact with Trp409. 
Moreover, the compound was very far from the validated active 
site pocket which made this compound lesser active than the other 
compounds. The compound does not possess any other non-polar 
interactions other than Trp409 and Leu424. The binding analysis and 
the ligand interaction of this compound were depicted in Fig. 7.
The last compound benzylic acid was made to dock into the active site of 
the enzyme, and the docking score was found to be –4.272 kcal/mol. The 
hydroxyl group present in the compound was found to interact with the 
amino acid Trp587. Furthermore, the compound does not possess any 
other interaction apart from tryptophan. The benzyl group’s present in 
this compound was well surrounded by non-polar interactions Val649 
and Met589. Since this compound possesses only one interaction, 
the docking score was lesser than the other compounds. The binding 
analysis and docking score of this compound were depicted in Fig. 8.
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